The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood ...

Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...

Among key components of drive is digital ‘thikri pehra’, installation of night-vision CCTV cameras and sound recording ...

The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for ...

FDA inspections are essential to ensuring the safety and quality of products in the food, pharmaceutical, and medical device industries. One of the experienced professionals in this field is John ...

Request To Download Free Sample of This Strategic Report @ What is Saudi Arabia Advanced Dermatology Drug Delivery Devices Market ? The Saudi Arabian Advanced Dermatology Drug Delivery Devices Market ...

Boise police found explosive devices during what began as a drug investigation. BPD’s Bomb Squad was called out, and ...

The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that ...

The U.S. Food and Drug Administration on Friday cleared the first blood test for the diagnosis of Alzheimer's disease.

Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was forced out.

The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker ...